|
Reid, Mary E; Duffield-Lillico, Anna J; Slate, Elizabeth et al. (2008) The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer 60:155-63
|
|
Reid, Mary E; Duffield-Lillico, Anna J; Sunga, Annette et al. (2006) Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 118:1777-81
|
|
Hutson, Alan D; Reid, Mary E (2004) The utility of partial cross-over designs in early phase randomized prevention trials. Control Clin Trials 25:493-501
|
|
Duffield-Lillico, Anna J; Slate, Elizabeth H; Reid, Mary E et al. (2003) Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95:1477-81
|
|
Duffield-Lillico, A J; Dalkin, B L; Reid, M E et al. (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91:608-12
|
|
McCulloch, C E; Lin, H; Slate, E H et al. (2002) Discovering subpopulation structure with latent class mixed models. Stat Med 21:417-29
|
|
Reid, Mary E; Duffield-Lillico, Anna J; Garland, Linda et al. (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11:1285-91
|
|
Nelson, Mark A; Reid, Mary; Duffield-Lillico, Anna J et al. (2002) Prostate cancer and selenium. Urol Clin North Am 29:67-70
|
|
Duffield-Lillico, Anna J; Reid, Mary E; Turnbull, Bruce W et al. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11:630-9
|
|
Clark, L C; Dalkin, B; Krongrad, A et al. (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730-4
|
Showing the most recent 10 out of 13 publications
